Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will need to be serious discussions about data architecture, security, and funding when the crisis is over.

As a leading provider of data and technology solutions, Allscripts (NASDAQ: MDRX) business unit, Veradigm, is at the forefront of the fight to help providers and researchers, and the patients they serve. The company is committed to leveraging its technology to help providers identify patients at risk for the virus and ensure they have the information and tools needed to help them.

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current pandemic.

The COVID-19 outbreak has been declared a pandemic by the World Health Organization, causing huge impact on people's lives, families and communities. With the increasing number of infections each day, combining assessment of CT imaging scans with clinical findings could facilitate early diagnosis of COVID-19 Pneumonia, thus allowing for early intervention.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and UK HealthCare, the clinical enterprise of the University of Kentucky, announced a collaboration to create Kentucky's only operating clinical command center for tele-critical care and operational optimization.

The EU funded programme called X-Europe aims to foster the growth of the leading European deeptech startups by providing top-notch training and services, and guiding partnerships with investors, corporations, and governments. The programme is delivered by five leaders in the startup community - F6S, TNW, Design Terminal, Growth Tribe, and TechChill.

SilverCloud Health, the world's leading digital mental health platform for providers, health plans and employers is to enhance its range of therapy programmes in the UK as part of expansion plans after securing $16m (~13m pounds sterling) funding from leading health investment groups.